Sign in

CIK 0001512762

  • Accelerated filer
  • Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273615821
Phone
+1 650-649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Other acquisition Director acquired 335,507 shares (other)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Other acquisition President & CEO acquired 4,303 shares (other)
  7. 4 Other acquisition President & CEO acquired 1,631 shares (other)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Other disposition Director disposed of 221,538 shares (other)
  11. 4 Gift Lanfear Dennis M gave 20,000 shares (gift)
  12. 4 Conversion 10% owner acquired 2,499,499 shares (conversion)
  13. 4 Conversion Director acquired 869,964 shares (conversion)
  14. 4 Open-market buy Director bought 425,926 shares at $13.50 ($5,750,001)
  15. 4 Conversion Former 10% Owner acquired 2,867,426 shares (conversion)
  16. 4 Option exercise Director acquired 26,505 shares (option exercise)
  17. 4 Conversion Lanfear Dennis M acquired 107,875 shares (conversion)
  18. 4 Conversion Director acquired 2,500,920 shares (conversion)
  19. 4 Conversion Chief Medical Officer acquired 26,791 shares (conversion)
  20. 4 Option exercise Chief Scientific Officer acquired 239,952 shares (option exercise)

Page 19 of 20 · 399 filings